Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis
- PMID: 22069462
- PMCID: PMC3206020
- DOI: 10.1371/journal.pone.0026675
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis
Abstract
Tuberculosis is still a leading cause of death worldwide. The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Recently, two different classes of chemical series, the benzothiazinones (BTZ) and the dinitrobenzamide (DNB) derivatives have been found to be highly active against M. tuberculosis, including XDR-TB strains. The target of BTZs is DprE1 protein which works in concert with DprE2 to form the heteromeric decaprenylphosphoryl-β-D-ribose 2'-epimerase, involved in Decaprenyl-Phospho-Arabinose (DPA) biosynthesis. Interestingly, it has been shown that the DNBs block the same pathway thus suggesting that both drugs could share the same target. Moreover, in Mycobacterium smegmatis the overexpression of the NfnB nitroreductase led to the inactivation of the BTZs by reduction of a critical nitro-group to an amino-group. In this work several spontaneous M. smegmatis mutants resistant to DNBs were isolated. Sixteen mutants, showing high levels of DNB resistance, exhibited a mutation in the Cys394 of DprE1. Using fluorescence titration and mass spectrometry it has been possible to monitor the binding between DprE1 and DNBs, achieving direct evidence that MSMEG_6382 is the cellular target of DNBs in mycobacteria. Additionally, M. smegmatis mutants having low levels of resistance to DNBs harbor various mutations in MSMEG_6503 gene encoding the transcriptional repressor of the nitroreductase NfnB. By LC/MS analysis it has been demonstrated that NfnB is responsible for DNB inactivation. Taken together, our data demonstrate that both DNB and BTZ drugs share common resistance mechanisms in M. smegmatis.
Conflict of interest statement
Figures


Similar articles
-
Decaprenylphosphoryl-β-D-ribose 2'-epimerase, the target of benzothiazinones and dinitrobenzamides, is an essential enzyme in Mycobacterium smegmatis.PLoS One. 2011 Feb 8;6(2):e16869. doi: 10.1371/journal.pone.0016869. PLoS One. 2011. PMID: 21346818 Free PMC article.
-
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.Mol Microbiol. 2010 Sep;77(5):1172-85. doi: 10.1111/j.1365-2958.2010.07277.x. Mol Microbiol. 2010. PMID: 20624223
-
Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target.Curr Med Chem. 2010;17(27):3099-108. doi: 10.2174/092986710791959693. Curr Med Chem. 2010. PMID: 20629622 Review.
-
Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis.J Am Chem Soc. 2010 Oct 6;132(39):13663-5. doi: 10.1021/ja106357w. J Am Chem Soc. 2010. PMID: 20828197
-
Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.Appl Microbiol Biotechnol. 2012 May;94(4):907-16. doi: 10.1007/s00253-012-4013-4. Epub 2012 Apr 18. Appl Microbiol Biotechnol. 2012. Retraction in: Appl Microbiol Biotechnol. 2012 Sep;95(5):1369. doi: 10.1007/s00253-012-4217-7. PMID: 22526781 Retracted. Review.
Cited by
-
Diaminoglyoxime as a versatile reagent in the synthesis of bis(1,2,4-oxadiazoles), 1,2,4-oxadiazolyl-quinazolines and 1,2,4-oxadiazolyl-benzothiazinones.Mol Divers. 2014 Nov;18(4):769-76. doi: 10.1007/s11030-014-9536-4. Epub 2014 Aug 13. Mol Divers. 2014. PMID: 25115630
-
An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates.Sci Rep. 2024 Oct 21;14(1):24792. doi: 10.1038/s41598-024-75818-y. Sci Rep. 2024. PMID: 39433543 Free PMC article.
-
Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents.J Am Chem Soc. 2013 Mar 6;135(9):3539-49. doi: 10.1021/ja311058q. Epub 2013 Feb 25. J Am Chem Soc. 2013. PMID: 23402278 Free PMC article.
-
Syntheses and Antituberculosis Activity of 1,3-Benzothiazinone Sulfoxide and Sulfone Derived from BTZ043.ACS Med Chem Lett. 2014 Nov 29;6(2):128-33. doi: 10.1021/ml5003458. eCollection 2015 Feb 12. ACS Med Chem Lett. 2014. PMID: 25699139 Free PMC article.
-
Mutations in rv0678 Confer Low-Level Resistance to Benzothiazinone DprE1 Inhibitors in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0090422. doi: 10.1128/aac.00904-22. Epub 2022 Aug 3. Antimicrob Agents Chemother. 2022. PMID: 35920665 Free PMC article.
References
-
- Zumla A, Mwaba P, Huggett J, Kapata N, Chanda D, et al. Reflections on the white plague. Lancet Infect Dis. 2009;9:197–202. - PubMed
-
- Jain A, Mondal R. Extensively drug-resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol. 2008;53:145–150. - PubMed
-
- Zignol M, Hosseini MS, Wright A, Weezenbak CL, Nunn P, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194:479–485. - PubMed
-
- Riccardi G, Pasca MR, Buroni S. Mycobacterium tuberculosis: drug resistance and future perspectives. Future Microbiol. 2009;4:597–614. - PubMed
-
- Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest. 2009;136:420–425. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases